SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-151938
Filing Date
2021-05-05
Accepted
2021-05-05 17:23:03
Documents
13
Period of Report
2021-05-05
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d362568d8k.htm   iXBRL 8-K 38687
2 EX-99.1 d362568dex991.htm EX-99.1 20194
  Complete submission text file 0001193125-21-151938.txt   193149

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gwph-20210505.xsd EX-101.SCH 3065
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20210505_lab.xml EX-101.LAB 18069
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20210505_pre.xml EX-101.PRE 11380
6 EXTRACTED XBRL INSTANCE DOCUMENT d362568d8k_htm.xml XML 3524
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35892 | Film No.: 21894632
SIC: 2834 Pharmaceutical Preparations